David D. Allison - 08 Jul 2022 Form 4 Insider Report for CinCor Pharma, Inc.

Role
Director
Signature
/s/ Cathy Rude, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
08 Jul 2022
Net transactions value
+$12,501
Form type
4
Filing time
20 Jul 2022, 16:44:12 UTC
Previous filing
17 Jun 2022
Next filing
12 Oct 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CINC Stock Option (Right to Buy) Award $12,501 +881 $14.19 881 08 Jul 2022 Common Stock 881 $20.20 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy in lieu of retainer fees of $12,500.